# 4AP for Carpal Tunnel Syndrome (CTS)

> **NCT06294821** · PHASE2 · NOT_YET_RECRUITING · sponsor: **John Elfar** · enrollment: 160 (estimated)

## Conditions studied

- Compression Neuropathy
- Carpal Tunnel Syndrome

## Interventions

- **DRUG:** 4-Aminopyridine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06294821
- **Lead sponsor:** John Elfar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11
- **Primary completion:** 2027-12
- **Final completion:** 2028-07
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06294821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06294821, "4AP for Carpal Tunnel Syndrome (CTS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06294821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*